Home
Reels
Grupos
Páginas
Más
Grupos Páginas Eventos Blogs Ofertas Empleos Courses Películas Merits
Iniciar sesión Registrarse
Theme Switcher
Night Mode
Patrocinados
Roche’s HER2-Positive Breast Cancer Therapies: Expanding Leadership in Treatment
Expansion into the Adjuvant Setting Roche has reinforced its position in the HER2-positive breast cancer treatment market by entering the adjuvant therapy space. Approvals for PERJETA and HERCEPTIN in early-stage HER2-positive breast cancer have strengthened the company’s portfolio, offering improved patient outcomes. Combining PERJETA and HERCEPTIN with chemotherapy has become a key...
0 Commentarios ·0 Acciones ·62 Views ·0 Vista previa
Please log in to like, share and comment!
Patrocinados
Upgrade to Pro
Choose the Plan That's Right for You
Upgrade
Patrocinados
Patrocinados